Jove
Visualize
Contact Us

Related Experiment Videos

Diabetic nephropathy

G C Groggel1

  • 1Department of Internal Medicine, University of Nebraska Medical Center, Omaha, USA.

Archives of Family Medicine
|October 1, 1996
PubMed
Summary

Diabetic nephropathy, a complication of diabetes, is a leading cause of kidney failure. Recent studies highlight glucose control and ACE inhibitors as key treatments for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glomerulonephritis with associated hypocomplementemia and crescents: an unusual case of fibrillary glomerulonephritis.

Journal of the American Society of Nephrology : JASN·1995
Same author

Insulin-like growth factor-1 stimulates production of mesangial cell matrix components.

Clinical nephrology·1995
Same author

Heparan sulfate stimulates extracellular matrix protein synthesis by mesangial cells in culture.

Nephron·1995
Same author

Production of an inhibitor of rat mesangial cell growth by the glomerulus and its alteration in puromycin nephrosis.

Journal of the American Society of Nephrology : JASN·1993
Same author

Acute thrombosis of the renal transplant artery: a case report and review of the literature.

Clinical nephrology·1991
Same author

Proteoglycan and glycosaminoglycan synthesis by cultured rat mesangial cells.

Journal of cellular physiology·1991
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic nephropathy is a significant microvascular complication in both types of diabetes mellitus.
  • It represents the primary cause of end-stage renal disease (ESRD).

Purpose of the Study:

  • To review the natural course, pathogenesis, clinical evaluation, and treatment of diabetic nephropathy.
  • To emphasize recent research on glucose control and angiotensin-converting enzyme (ACE) inhibitors.

Main Methods:

  • Literature review focusing on diabetic nephropathy.
  • Analysis of recent studies concerning glucose management.
  • Evaluation of research on ACE inhibitors for diabetic nephropathy treatment.

Main Results:

  • Diabetic nephropathy is a major cause of ESRD.
  • Glucose control and ACE inhibitors show promise in managing diabetic nephropathy.

Conclusions:

  • Effective management of diabetic nephropathy is crucial for preventing ESRD.
  • Further research into glucose control and ACE inhibitors is warranted.

Related Experiment Videos